The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126915431 12691543 1 I 20130410 20160826 20160826 EXP US-VALIDUS PHARMACEUTICALS LLC-US-2013VAL000658 VALIDUS 0.00 Y 0.00000 20160826 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126915431 12691543 1 PS CALCITRIOL. CALCITRIOL 1 Oral 1 MG, 3 IN 1 WK U 21068 1 MG ORAL SOLUTION
126915431 12691543 2 C CALCIUM GLUCONATE. CALCIUM GLUCONATE 1 Intravenous (not otherwise specified) 1500 MG, UNK U 0 1500 MG
126915431 12691543 3 C ERGOCALCIFEROL. ERGOCALCIFEROL 1 Oral 8000 IU, QD U 0 8000 IU
126915431 12691543 4 C FERROUS SULFATE. FERROUS SULFATE 1 Oral 2 ML, QD U 0 2 ML
126915431 12691543 5 C FOLIC ACID. FOLIC ACID 1 Oral 0.2 ML, QD U 0 .2 ML
126915431 12691543 6 C CITRIC ACID CITRIC ACID MONOHYDRATE 1 Topical UNK U 0
126915431 12691543 7 C ERYPED ERYTHROMYCIN ETHYLSUCCINATE 1 Oral /5ML 200 MG U 0 200 MG
126915431 12691543 8 C LEVOXYL LEVOTHYROXINE SODIUM 1 Oral 25 ?G, 1 IN 1 D U 0 25 UG TABLET
126915431 12691543 9 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 Oral 10 MG, 2 IN 1 D U 0 10 MG
126915431 12691543 10 C REGLAN METOCLOPRAMIDE HYDROCHLORIDE 1 Oral 5 MG, 4 IN 1 D U 0 5 MG SYRUP
126915431 12691543 11 C EPOETIN ALFA ERYTHROPOIETIN 1 2000 UNITS/ML, QD U 0 SOLUTION FOR INJECTION
126915431 12691543 12 C NYSTATIN. NYSTATIN 1 Topical 100000 UNITS/G, 4 IN 1 D U 0 OINTMENT

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126915431 12691543 1 Chronic kidney disease-mineral and bone disorder
126915431 12691543 2 Product used for unknown indication
126915431 12691543 3 Product used for unknown indication
126915431 12691543 4 Product used for unknown indication
126915431 12691543 5 Product used for unknown indication
126915431 12691543 6 Product used for unknown indication
126915431 12691543 7 Product used for unknown indication
126915431 12691543 8 Product used for unknown indication
126915431 12691543 9 Product used for unknown indication
126915431 12691543 10 Product used for unknown indication
126915431 12691543 11 Product used for unknown indication
126915431 12691543 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126915431 12691543 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126915431 12691543 Cough
126915431 12691543 Dehydration
126915431 12691543 Gastroenteritis
126915431 12691543 Hypotension
126915431 12691543 Nausea
126915431 12691543 Retching
126915431 12691543 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126915431 12691543 1 20120730 0
126915431 12691543 2 20121013 0
126915431 12691543 3 20130306 0
126915431 12691543 4 20120223 0
126915431 12691543 5 20120223 0
126915431 12691543 6 20121116 0
126915431 12691543 7 20121018 0
126915431 12691543 8 20130306 0
126915431 12691543 9 20120727 0
126915431 12691543 10 20121018 0
126915431 12691543 11 20120125 0
126915431 12691543 12 20121116 0